Table 6.
Variables | At admission |
At discharge |
||
---|---|---|---|---|
r | p | r | p | |
CD3+ lymphocytes, ×106/l | ||||
Total | −0.4424 | <0.0001**** | −0.2113 | 0.0020** |
Non-severe | −0.3543 | <0.0001**** | −0.2108 | 0.0045** |
Severe | −0.5787 | <0.0001**** | 0.1945 | 0.2861 |
CD4+CD3+ lymphocytes, ×106/l | ||||
Total | −0.4121 | <0.0001**** | −0.2139 | 0.0017** |
Non-severe | −0.3128 | <0.0001**** | −0.2106 | 0.0044** |
Severe | −0.5624 | <0.0001**** | 0.1943 | 0.2866 |
CD8+CD3+ lymphocytes, ×106/l | ||||
Total | −0.3910 | <0.0001**** | −0.2148 | 0.0018** |
Non-severe | −0.3054 | <0.0001**** | −0.1978 | 0.0079** |
Severe | −0.5319 | <0.0001**** | −0.1195 | 0.5370 |
NLR | ||||
Total | 0.3972 | <0.0001**** | 0.2557 | <0.0001**** |
Non-severe | 0.2835 | <0.0001**** | 0.2260 | 0.0001*** |
Severe | 0.6588 | <0.0001**** | 0.2525 | 0.0868 |
Neutrophil count, ×109/l | ||||
Total | 0.1673 | 0.0013** | 0.1459 | 0.0057** |
Non-severe | 0.0741 | 0.1878 | 0.1414 | 0.0125* |
Severe | 0.5454 | <0.0001**** | 0.2619 | 0.0753 |
TLC, ×109/l | ||||
Total | −0.3996 | <0.0001**** | −0.1921 | 0.0003*** |
Non-severe | −0.3161 | <0.0001**** | −0.1394 | 0.0139* |
Severe | −0.4688 | <0.0001**** | −0.1496 | 0.3154 |
CRP, mg/l | ||||
Total | 0.5966 | <0.0001**** | 0.2669 | <0.0001**** |
Non-severe | 0.5393 | <0.0001**** | 0.2459 | <0.0001**** |
Severe | 0.5898 | <0.0001**** | 0.3560 | 0.0223* |
p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
C3, complement 3; C4, complement 4; CD4+/CD8+, the ratio of CD4+ lymphocyte counts to CD8+ lymphocyte counts; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; Ig, immunoglobulin; LDH, lactate dehydrogenase; NLR, neutrophil-to-lymphocyte ratio; r, correlation coefficient; TLC, total lymphocyte count.